Today: 8 June 2026
Walmart stock slips after earnings: what to know before Monday’s open
22 February 2026
2 mins read

Walmart stock slips after earnings: what to know before Monday’s open

New York, February 22, 2026, 11:16 EST — Market closed

  • Walmart shares finished Friday at $122.99, dropping 1.5% and stretching their two-day slide that followed the company’s outlook.
  • The stock stayed under pressure after a cautious profit outlook, plus a new analyst downgrade—even as the company rolled out a buyback and boosted its dividend.
  • This week, investors are eyeing U.S. consumer data for any signals on spending habits and inflation trends.

Walmart Inc dropped 1.5% by Friday’s close, the stock slipping as investors weighed a cautious outlook from the retailer and fresh analyst commentary ahead of the coming week.

Walmart’s position near the heart of U.S. household budgets gives its moves extra weight. A cautious stance here can spill over to other consumer staples and big-box players—especially now, after the stock’s strong rally raised expectations.

Macro signals remain firmly on traders’ radar. Retailers are still wrestling with persistent costs, fickle demand, and tariff chatter—plus, any hint of consumer confidence slipping usually turns up in staples first.

Walmart’s Thursday filing showed fourth-quarter revenue landing at $190.66 billion, with adjusted earnings per share coming in at $0.74. Looking ahead, the retailer is projecting fiscal 2027 adjusted EPS between $2.75 and $2.85, and sees first-quarter adjusted EPS in a $0.63 to $0.65 range. The company’s “adjusted” numbers exclude certain items, and “constant currency” results back out FX impacts. Walmart also rolled out a fresh $30 billion share buyback plan and noted that U.S. comparable sales—stores open at least a year—were up 4.6%. https://www.sec.gov/Archives/edgar/data/10…

Walmart bumped up its annual dividend to $0.99 a share—5% higher than before—with quarterly payouts set at $0.2475. “Dividends continue to be a part of our diversified capital returns approach,” Chief Financial Officer John David Rainey said in the announcement. https://corporate.walmart.com/news/2026/02…

HSBC cut Walmart to “hold” from “buy” on Friday, flagging what it called weak guidance despite a relatively steady consumer backdrop. The analysts wrote, “It is hard to see a marked deterioration in the trading environment,” but suggested near-term momentum “may be limited.” Truist Securities took a different tack in its own note, bumping up its price target to $139 and sticking with a buy. https://www.investing.com/news/stock-marke… https://www.investing.com/news/analyst-rat…

Friday’s pullback landed even as the major indexes closed in positive territory. Investors kept shifting between growth names and defensive plays. Target picked up 0.9% during the session; Walmart slipped 1.5%, MarketWatch data showed.

Bulls have to wrestle with a big caveat: Walmart’s outlook highlights nagging questions about costs, currency swings, and trade policy, while the stock itself long ago shed its supermarket discount. If consumers pull back more sharply or rivals ramp up price competition, the boost from advertising and membership fees might not be enough to protect margins right away.

Tuesday brings a new look at consumer sentiment—February’s consumer confidence numbers from the Conference Board drop at 10:00 a.m. ET.

The Producer Price Index for January lands Friday at 8:30 a.m. ET, and investors will be quick to scrutinize fresh supply chain inflation numbers. The report tends to jolt rate forecasts—and that can ripple through retail valuations.

Walmart faces its next hurdle when the market reopens Monday, as investors weigh whether to return. Tuesday brings the consumer confidence reading, a data point that could sway sentiment on spending as March approaches.

Stock Market Today

  • KOSPI Index Plunges Amid Global Market Turmoil
    June 8, 2026, 9:07 AM EDT. South Korea's KOSPI experienced a sharp crash triggered by margin stress in chip stocks and a circuit breaker trading halt. The selloff in global markets was fueled by a strong U.S. jobs report signaling prolonged high interest rates, fears of a yen carry trade unwind amid Bank of Japan tightening, and a crypto selloff following Zcash network vulnerabilities. U.S. futures rebounded slightly as chip stocks recovered, with investors focused on upcoming inflation data and SpaceX's anticipated IPO. Rising Middle East tensions keep oil prices elevated near $94 per barrel. The volatile market reflects growing concerns over liquidity absorption from the SpaceX listing, geopolitical risks, and tightening monetary policies globally.

Latest articles

Plug Power Stock Faces a Make-or-Break Week After Friday’s 10% Drop

Plug Power Stock Faces a Make-or-Break Week After Friday’s 10% Drop

8 June 2026
Plug Power rose 2.95% to $3.31 in Monday pre-market trading after a $39.2 million federal tax credit sale tied to its St. Gabriel hydrogen facility, as investors await CEO Jose Luis Crespo’s June 11 update on liquidity and asset sales amid ongoing losses and a recent 10.69% stock drop.
ABAT Shares Jump on DOE’s $115M Lithium Grant Return

ABAT Shares Jump on DOE’s $115M Lithium Grant Return

8 June 2026
American Battery Technology Co shares soared 29.58% to $4.03 premarket after the U.S. Department of Energy fully reinstated a $115 million grant for its Nevada lithium refinery, restoring federal funding for the Tonopah Flats Lithium Project with no change to awarded funds or milestones, though risks remain from permitting, financing, and volatile lithium prices.
NANO Nuclear Stock Bounces, Investors Eye What’s Next

NANO Nuclear Stock Bounces, Investors Eye What’s Next

8 June 2026
NANO Nuclear Energy jumped 7.8% to $25.40 in premarket trading after a 9.9% Friday drop, as traders weighed fresh insider sales filings and recent regulatory progress on its KRONOS microreactor project; the company held $568.7 million in cash as of March 31, but faces sector-wide volatility and execution risks.
Nurix Shares Jump Premarket on Roche $2.3 Billion Cancer Drug Deal

Nurix Shares Jump Premarket on Roche $2.3 Billion Cancer Drug Deal

8 June 2026
Nurix soared 20.4% to $17.62 premarket after Roche agreed to pay $700 million up front in a bexobrutideg collaboration worth up to $2.3 billion, a major cash boost and external validation for Nurix’s lead blood cancer drug ahead of a planned Phase 3 trial, with Roche’s clinical and commercial backing now in play.
Salesforce stock (CRM) steadies, but Wall Street trims targets again ahead of Feb. 25 results
Previous Story

Salesforce stock (CRM) steadies, but Wall Street trims targets again ahead of Feb. 25 results

Johnson & Johnson stock price: JNJ heads into Monday as Tremfya data lands and dividend date nears
Next Story

Johnson & Johnson stock price: JNJ heads into Monday as Tremfya data lands and dividend date nears

Go toTop